Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BYClinical case reports

Case Report: Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B‐Cell Depletion Therapy to Ravulizumab

  1. 1University of Cincinnati

Related

  1. Utility of Blood Neutrophil to Diagnose Bacterial Infections under Satralizumab Treatment for Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Report of Two Cases
    Hiroshi Kuroda, Kazuo Fujihara, Chikako Kaneko +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  2. Struma Ovarii: Radiological Features and Diagnostic Challenges
    Carolina Tim-Tim, Teresa Margarida Cunha
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Diagnostic challenges of masked arginine vasopressin deficiency in neurosarcoidosis complicated by sodium–glucose cotransporter 2 inhibitor use
    JCEM case reportsPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  4. Self-inflicted thoracoabdominal nail-gun injury presenting as STEMI: diagnostic challenges in a time-critical care pathway
    Journal of surgical case reportsPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  5. Pulmonary Epithelioid Trophoblastic Tumor Without Demonstrable Uterine Involvement: A Case Report and Literature Review Highlighting Diagnostic Challenges and Multidisciplinary Management
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{zabeti2026case,
  title = {{Case Report: Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B‐Cell Depletion Therapy to Ravulizumab}},
  author = {Aram Zabeti},
  journal = {Clinical case reports},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655658},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Case Report: Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B‐Cell Depletion Therapy to Ravulizumab
AU  - Aram Zabeti
PY  - 2026
DA  - 2026/10/01
JO  - Clinical case reports
UR  - https://europepmc.org/article/PMC/PMC13655658
SN  - 2050-0904
ER  -